Nexalin Technology (NXL) Cash & Equivalents (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Cash & Equivalents of $1.2 million for Q1 2026, up 94.19% year-over-year from $622029.0 in Q1 2025, and down 60.63% quarter-over-quarter from $3.1 million in Q4 2025.
Nexalin Technology (NXL) Cash & Equivalents (2021 - 2026) Analysis & Trends
Nexalin Technology's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 94.19% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 94.19% YoY), while the FY2025 annual figure was $3.1 million, up 434.12% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $1.2 million, down from $3.1 million in the prior quarter.
- The five-year high for Cash & Equivalents was $7.9 million in Q3 2022, with the low at $162743.0 in Q4 2022.
- The 5-year median for Cash & Equivalents is $1.2 million (2026), against an average of $2.4 million.
- Peak annual rise in Cash & Equivalents reached 434.12% in 2025, while the deepest fall reached 86.92% in 2025.
- Nexalin Technology's Cash & Equivalents stood at $162743.0 in 2022, then soared by 256.53% to $580230.0 in 2023, then declined by 0.99% to $574485.0 in 2024, then jumped by 434.12% to $3.1 million in 2025, then sank by 60.63% to $1.2 million in 2026.
- Business Quant data shows NXL's Cash & Equivalents at $1.2 million in Q1 2026, $3.1 million in Q4 2025, and $590075.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | 590,075.00 |
| Jun 30, 2025 | 431,320.00 |
| Mar 31, 2025 | 622,029.00 |
| Dec 31, 2024 | 574,485.00 |
| Sep 30, 2024 | 4.51 Mn |
| Jun 30, 2024 | 848,796.00 |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 580,230.00 |
| Sep 30, 2023 | 3.58 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 162,743.00 |
| Sep 30, 2022 | 7.86 Mn |
| Dec 31, 2021 | 661,778.00 |